Graphene Oxide Nanoscale Platform Enhances the Anti-Cancer Properties of Bortezomib in Glioblastoma Models (2022)
Attributed to:
2D Materials for Next Generation Healthcare Technologies (2D-Health)
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/adhm.202201968
PubMed Identifier: 36300643
Publication URI: http://europepmc.org/abstract/MED/36300643
Type: Journal Article/Review
Parent Publication: Advanced Healthcare Materials
Issue: 3
ISSN: 2192-2640